JPH09286709A - Preparation for external use for skin - Google Patents
Preparation for external use for skinInfo
- Publication number
- JPH09286709A JPH09286709A JP8121027A JP12102796A JPH09286709A JP H09286709 A JPH09286709 A JP H09286709A JP 8121027 A JP8121027 A JP 8121027A JP 12102796 A JP12102796 A JP 12102796A JP H09286709 A JPH09286709 A JP H09286709A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- royal jelly
- undefined undefined
- external preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 52
- 229940109850 royal jelly Drugs 0.000 claims abstract description 16
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 240000007594 Oryza sativa Species 0.000 claims abstract description 9
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 6
- 241001474977 Palla Species 0.000 claims abstract description 4
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims abstract description 3
- 244000236658 Paeonia lactiflora Species 0.000 claims abstract description 3
- 240000002547 Rosa roxburghii Species 0.000 claims abstract description 3
- 235000000640 Rosa roxburghii Nutrition 0.000 claims abstract description 3
- 241000736199 Paeonia Species 0.000 claims description 8
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 7
- 244000062730 Melissa officinalis Species 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 241000411851 herbal medicine Species 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 4
- 244000178870 Lavandula angustifolia Species 0.000 claims description 4
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 4
- 235000004496 Oenothera biennis Nutrition 0.000 claims description 4
- 239000001102 lavandula vera Substances 0.000 claims description 4
- 235000018219 lavender Nutrition 0.000 claims description 4
- 229940010454 licorice Drugs 0.000 claims description 4
- 241000219925 Oenothera Species 0.000 claims description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 9
- 240000004371 Panax ginseng Species 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 241000213996 Melilotus Species 0.000 abstract description 2
- 235000016311 Primula vulgaris Nutrition 0.000 abstract description 2
- 239000001417 melissa officinalis l. Substances 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 206010040849 Skin fissures Diseases 0.000 abstract 2
- 244000028344 Primula vulgaris Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 210000000434 stratum corneum Anatomy 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000020710 ginseng extract Nutrition 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 241000220317 Rosa Species 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- -1 jojoba oil Substances 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 241000202807 Glycyrrhiza Species 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241000257303 Hymenoptera Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 235000011449 Rosa Nutrition 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229940045761 evening primrose extract Drugs 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940083980 lavender extract Drugs 0.000 description 2
- 235000020723 lavender extract Nutrition 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 241000517645 Abra Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 235000017822 Melilotus officinalis Nutrition 0.000 description 1
- 240000000366 Melilotus officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000219929 Onagraceae Species 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000245063 Primula Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- PJDFMXWUFDUYTG-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;hexadecyl sulfate Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOS(O)(=O)=O PJDFMXWUFDUYTG-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 229940021231 clearskin Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 150000002027 dodecanoic acid esters Chemical class 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は皮膚外用剤、特に肌
荒れ防止、肌荒れ改善効果の高い皮膚外用剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation, and more particularly to a skin external preparation which is highly effective in preventing and improving skin roughness.
【0002】[0002]
【従来の技術および発明が解決しようとする課題】従
来、天然物から抽出した各種原料、たとえばタンパク
質、多糖、抽出エキス、天然高分子等が、その使用効果
が特徴的であるため皮膚外用剤に配合されてきた。しか
しながらその効果はいまだ十分でなく、肌荒れ防止、肌
荒れ改善効果において十分な優れた効果が望まれてい
た。2. Description of the Related Art Conventionally, various raw materials extracted from natural products such as proteins, polysaccharides, extracted extracts, and natural polymers have been used as skin external preparations because of their characteristic use effects. It has been blended. However, the effect is not yet sufficient, and a sufficiently excellent effect for preventing rough skin and improving rough skin has been desired.
【0003】[0003]
【課題を解決するための手段】本発明者らは肌荒れ防
止、肌荒れ改善効果を高める方法はないものかと鋭意研
究した結果、ロ−ヤルゼリ−の抽出物と、高麗人参(Pan
ax ginseng) の抽出物と、植物生薬の1種又は2種とを
配合することによって、この目的が達成できることを見
出して本発明を完成するに至った。すなわち、本発明の
請求項1は、ローヤルゼリー抽出物と、高麗人参(Pana
xGinseng)抽出物と、植物生薬とを配合することを特徴
とする皮膚外用剤である。本発明の請求項2は、請求項
1記載の皮膚外用剤において、植物生薬が米胚芽(Oryz
a sativa Linne) 、イザヨイバラ(Rosa roxburghii)、
月見草(Evenig primrose)、メリロート(Melilotus Of
ficinals) 、メリッサ(Melissa officinalis L.)、ラベ
ンダー(Lavandaula officinalis)、シャクヤク(Paeonia
lactiflora pallas) 、甘草(Glycyrrhiza glabra linn
e)から抽出された天然エキスの1種又は2種以上である
ことを特徴とする皮膚外用剤である。[Means for Solving the Problems] The inventors of the present invention have conducted diligent research as to whether or not there is a method for preventing skin roughness and enhancing the effect of improving skin roughness. As a result, an extract of royal jelly and ginseng (Pan)
The present invention has been completed by finding that this object can be achieved by blending an extract of ax ginseng) with one or two botanical herbs. That is, claim 1 of the present invention relates to royal jelly extract and ginseng (Pana)
xGinseng) extract and a botanical herbal medicine are blended together, which is an external preparation for skin. A second aspect of the present invention is the external preparation for skin according to the first aspect, wherein the herbal medicine is rice germ (Oryz.
a sativa Linne), yellow rose (Rosa roxburghii),
Evening primrose, Melilotus Of
ficinals), Melissa (Melissa officinalis L.), Lavender (Lavandaula officinalis), Peony (Paeonia)
lactiflora pallas), licorice (Glycyrrhiza glabra linn
An external preparation for skin, which is one or more natural extracts extracted from e).
【0004】以下本発明の構成について詳述する。本発
明で用いられるローヤルゼリーより抽出される抽出物
は、蜜蜂の若い働き蜂の頭部にある分泌腺から分泌され
る乳白色の粘液性物質であるローヤルゼリーをアルコー
ル、多価アルコール、その他各種有機溶媒、水、水性ア
ルコール等の抽出溶媒で抽出された天然エキス及び/又
は抽出物をさらに精製したものを配合することが好まし
い。The structure of the present invention will be described in detail below. The extract extracted from the royal jelly used in the present invention is royal jelly, which is a milky white mucous substance secreted from the secretory glands of the heads of young bees of bees, is alcohol, polyhydric alcohol, other various organic solvents, and water. It is preferable to blend a natural extract and / or extract further purified with an extraction solvent such as aqueous alcohol.
【0005】本発明で用いられる高麗人参の抽出物は、
アルコール、多価アルコール、その他各種有機溶媒、
水、水性アルコール等の抽出溶媒で抽出された天然エキ
ス及び/又は抽出物である。これら溶媒の中でも特にエ
タノールが好ましい。The ginseng extract used in the present invention is
Alcohol, polyhydric alcohol, other organic solvents,
A natural extract and / or extract extracted with an extraction solvent such as water or aqueous alcohol. Among these solvents, ethanol is particularly preferable.
【0006】本発明において用いられるローヤルゼリー
の抽出物及び高麗人参の抽出物の配合量は、皮膚外用剤
全量中、0.0001〜30重量%、好ましくは0.005 〜15重量
%である。0.0001重量%未満ではその効果は発揮されに
くく、30重量%を越えると製品の安定性上好ましくな
い。The amount of the royal jelly extract and ginseng extract used in the present invention is 0.0001 to 30% by weight, preferably 0.005 to 15% by weight, based on the total amount of the skin external preparation. If it is less than 0.0001% by weight, the effect is difficult to be exhibited, and if it exceeds 30% by weight, the stability of the product is not preferable.
【0007】本発明で用いられる植物生薬としては、米
胚芽(Oryza sativa Linne) 、イザヨイバラ(Rosa rox
burghii)、月見草(Evenig primrose)、メリロート(Me
lilotus Officinals) 、メリッサ(Melissa officinalis
L.)、ラベンダー(Lavandaula officinalis)、シャクヤ
ク(Paeonia lactiflora pallas) 、甘草(Glycyrrhizagl
abra linne)から抽出された天然エキスが最適である。
これらの植物生薬については、米胚芽、月見草は種子
部、イザヨイバラは果実部、メリロート、メリッサは葉
部、ラベンダーは花部、シャクヤク、甘草は根部を用い
るのが好ましい。これらの植物生薬は粉砕したものを配
合してもいいが、アルコール、多価アルコール、その他
各種有機溶媒、水、水性アルコール等の抽出溶媒で抽出
された天然エキス及び/又は抽出物をさらに精製したも
のを配合することが好ましい。The botanical herbs used in the present invention include rice germ (Oryza sativa Linne) and Rosa rox (Rosa rox).
burghii), Evening primrose (Evenig primrose), Merrilot (Me
lilotus Officinals), Melissa (Melissa officinalis)
L.), lavender (Lavandaula officinalis), peony (Paeonia lactiflora pallas), licorice (Glycyrrhizagl)
a natural extract extracted from abra linne) is most suitable.
With respect to these botanical herbs, it is preferable to use rice germ, seeds for evening primroses, fruits for Izayoi rose, leaves for melilot and melissa, flowers for lavender, roots for peony and licorice. These plant crude drugs may be blended in a pulverized form, but natural extracts and / or extracts extracted with alcohols, polyhydric alcohols, other organic solvents, water, extraction solvents such as aqueous alcohol, etc. were further purified. It is preferable to blend one.
【0008】本発明における植物生薬のうち、1種また
は2種以上を配合することができる。本発明における植
物生薬の配合量は皮膚外用剤全量中、各々0.0001〜30重
量%好ましくは各々0.005 〜15重量%である。0.0001重
量%未満ではその効果は発揮されにくく、30重量%を越
えると製品の安定性上好ましくない。[0008] Of the herbal medicines in the present invention, one kind or two or more kinds can be blended. The blending amount of the botanical crude drug in the present invention is 0.0001 to 30% by weight, preferably 0.005 to 15% by weight, based on the total amount of the skin external preparation. If it is less than 0.0001% by weight, the effect is difficult to be exhibited, and if it exceeds 30% by weight, the stability of the product is not preferable.
【0009】本発明の皮膚外用剤には上記した必須成分
の他に通常化粧品や医薬品等の皮膚外用剤に用いられる
他の成分、例えばアボガド油、パーム油、ピーナッツ
油、牛脂、ホホバ油、カルナバロウ、ミツロウ、キャン
デリラ、ラノリン、流動パラフィン、スクワラン、ミク
ロクリスタリンワックス、ステアリン酸、ラウリン酸エ
ステル類、ミリスチン酸エステル類、イソステアリルア
ルコール等の油分、グリセリン、ソルビトール、ポリエ
チレングリコール、ピロリドンカルボン酸およびその
塩、コラーゲン、ヒアルロン酸およびその塩、コンドロ
イチン硫酸およびその塩等の保湿剤、パラジメチルアミ
ノ安息香酸アミル、ウロカニン酸、ジイソプロピルケイ
ヒ酸エチル等の紫外線吸収剤、アスコルビン酸、α−ト
コフェロール、ジブチルヒドロキシトルエン、パラヒド
ロキシアニソール等の酸化防止剤、ステアリル硫酸ナト
リウム、セチル硫酸ジエタノールアミン、モノラウリン
酸ポリオキシエチレンソルビタン、イソステアリン酸ポ
リエチレングリコール、アシルメチルタウリン等の界面
活性剤、エチルパラベン、ブチルパラベン等の防腐剤、
オウバク、オウレン、シコン、センブリ、バーチ、ビワ
等の抽出物、グリチルリチン酸誘導体、グリチルレチン
酸誘導体、サリチル酸誘導体、ヒノキチオール、酸化亜
鉛、アラントイン等の消炎剤、胎盤抽出物、グルタチオ
ン、ユキノシタ抽出物、アスコルビン酸誘導体、、アル
ブチン等の美白剤、アロエ、ゼニアオイ、アイリス、ブ
ドウ、ヨクイニン、ヘチマ、ユリ等の抽出物、感光素、
コレステロール誘導体、各種アミノ酸類等の賦活剤、サ
フラン、センキュウ、ショウキョウ、オトギリソウ、オ
ノニス、ローズマリー、ニンニク等の抽出物、γ−オリ
ザノール、デキストラン硫酸ナトリウム、等の血行促進
剤、硫黄、チアントール等の抗脂漏剤、香料、水、アル
コール、カルボキシビニルポリマー等の増粘剤、乳酸、
クエン酸、グリコール酸等のpH調整剤、チタンイエロ
ー、カーサミン、ベニバナ赤等の色剤等を必要に応じて
適宜配合することができる。In addition to the above-mentioned essential components, the external preparation for skin of the present invention contains other components which are usually used in external preparations for skin such as cosmetics and pharmaceuticals, such as avocado oil, palm oil, peanut oil, beef tallow, jojoba oil, and carnauba wax. , Beeswax, candelilla, lanolin, liquid paraffin, squalane, microcrystalline wax, stearic acid, lauric acid esters, myristic acid esters, oil components such as isostearyl alcohol, glycerin, sorbitol, polyethylene glycol, pyrrolidonecarboxylic acid and salts thereof, Moisturizers such as collagen, hyaluronic acid and its salts, chondroitin sulfate and its salts, UV absorbers such as amyl paradimethylaminobenzoate, urocanic acid and ethyl diisopropylcinnamate, ascorbic acid, α-tocopherol, dibutyrate Antioxidants such as hydroxytoluene and parahydroxyanisole, sodium stearyl sulfate, diethanolamine cetyl sulfate, polyoxyethylene sorbitan monolaurate, polyethylene glycol isostearate, surfactants such as acylmethyltaurine, preservatives such as ethylparaben and butylparaben ,
Extracts such as Oataku, Oren, Sikon, Assemblies, Birch, Loquat, Glycyrrhizic acid derivatives, Glycyrrhetinic acid derivatives, Salicylic acid derivatives, Hinokitiol, Zinc oxide, Allantoin and other anti-inflammatory agents, Placenta extracts, Glutathione, Yukinoshita extracts, Ascorbic acid Derivatives, whitening agents such as arbutin, extracts such as aloe, mallow, iris, grapes, yoquinin, loofah, lily, photosensitizer,
Cholesterol derivatives, activators such as various amino acids, saffron, senkyu, ginger, extract of Hypericum, Ononis, rosemary, garlic, etc., γ-oryzanol, dextran sulfate, blood circulation promoters, sulfur, thianthol, etc. Antiseborrheic agent, fragrance, water, alcohol, thickener such as carboxyvinyl polymer, lactic acid,
A pH adjusting agent such as citric acid or glycolic acid, a coloring agent such as titanium yellow, carsamine, or safflower red can be appropriately blended as necessary.
【0010】本発明の皮膚外用剤は、化粧料、医薬品、
医薬部外品、外皮に適用されるものを、指し、その剤形
は水溶液系、可溶化系、乳化系、粉末系、油液系、ゲル
系、軟膏系、水−油2層系、水−油−粉末3層系など広
い形態を取り得る。The external preparation for skin of the present invention comprises cosmetics, pharmaceuticals,
Refers to quasi-drugs and those applied to the outer skin, and the dosage forms are aqueous system, solubilization system, emulsion system, powder system, oil liquid system, gel system, ointment system, water-oil two-layer system, water. It can take a wide variety of forms such as an oil-powder tri-layer system.
【0011】[0011]
【実施例】以下に実施例を挙げて本発明を具体的に説明
するが、本発明はこれらに限定されるものではない。
尚、配合量については、他に指定のない限り重量%で表
す。 〔肌荒れ改善試験〕健常人男性の背部皮膚を3%のドデ
シル硫酸ナトリウム水溶液で処理し、肌荒れを作成し
た。2時間後、各試料を20μl開放塗布した。これを
5日間繰り返し、6日目に目視により肌荒れの状態を観
察し、表1の基準に従がって採点した。評価が高い程肌
荒れ改善効果が高いことを示す。EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to these examples.
In addition, the blending amount is represented by wt% unless otherwise specified. [Rough skin improvement test] The back skin of a healthy man was treated with a 3% sodium dodecyl sulfate aqueous solution to prepare rough skin. After 2 hours, 20 μl of each sample was applied in an open manner. This was repeated for 5 days, and the condition of rough skin was visually observed on the 6th day, and was scored according to the criteria in Table 1. The higher the evaluation, the higher the effect of improving rough skin.
【0012】 (表1) ───────────────────────────────── 評点 評 点 の 基 準 ───────────────────────────────── 1 広範囲の角層の乾燥、めくれ、強い紅斑を認める。 2 角層の乾燥、めくれ、中程度の紅斑を認める。 3 角層の乾燥は認められるが、めくれは認められない。 弱い紅斑を認める。 4 角層の乾燥、めくれは認められないが、若干の紅斑を認める。 5 角層の乾燥、めくれ、紅斑共に認められない。 ─────────────────────────────────(Table 1) ───────────────────────────────── Rating criteria The criteria for rating ──── ───────────────────────────── 1 A wide range of stratum corneum dryness, swelling, and strong erythema are observed. 2 Dry, swelling and moderate erythema on the stratum corneum. 3 Dryness of the stratum corneum is observed, but no curling is observed. Weak erythema. 4 Dryness and turning of the stratum corneum are not observed, but some erythema is observed. 5 Dryness, swelling and erythema of the stratum corneum are not observed. ─────────────────────────────────
【0013】男性パネルは各群10人とし、10人の評
点の平均値を基に、各試料の肌荒れ改善効果を判定し
た。 判定 ◎:評価の平均が4以上 ○:評点の平均が3以上4未満 △:評点の平均が2以上3未満 ×:評点の平均が2未満 (表2) ──────────────────────────────────── 実 施 例 比較例 試 料 1 2 3 4 5 6 7 8 9 10 1 2 ──────────────────────────────────── ローヤルゼリーエキス 5 5 5 5 5 5 5 5 5 5 5 0 高麗人参エキス 5 5 5 5 5 5 5 5 5 5 5 0 米胚芽エキス 3 0 0 0 0 0 0 0 0 0 0 0 イザヨイバラエキス 0 3 0 0 0 0 0 0 0 0 0 0 月見草エキス 0 0 3 0 0 0 0 0 3 0 0 3 メリロートエキス 0 0 0 3 0 0 0 0 0 0 0 0 メリッサエキス 0 0 0 0 3 0 0 0 0 3 0 0 ラベンダーエキス 0 0 0 0 0 3 0 0 0 0 0 0 シャクヤクエキス 0 0 0 0 0 0 3 0 3 0 0 0 甘草エキス 0 0 0 0 0 0 0 3 0 3 0 0 POE(20) ソルヒ゛タンモノラウリン酸エステル 0.5 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 POE(15) ラウリルアルコールエーテル 0.5 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 アルコール 8 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 香料 適量〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 防腐剤 適量〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 クエン酸 0.2 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 精製水 残 余 ──────────────────────────────────── 評 価 ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ △ △Each male group consisted of 10 persons, and the skin roughening improving effect of each sample was judged based on the average value of the scores of 10 persons. Judgment ◎: Average rating is 4 or more ○: Average rating is 3 or more and less than 4 Δ: Average rating is 2 or more and less than 3 ×: Average rating is less than 2 (Table 2) ────────── ─────────────────────────── Actual examples Comparative examples Samples 1 2 3 4 5 6 7 8 9 9 10 1 2 ──── ──────────────────────────────── Royal Jelly Extract 5 5 5 5 5 5 5 5 5 5 5 5 5 0 Ginseng Extract 5 5 5 5 5 5 5 5 5 5 5 5 0 Rice germ extract 3 0 0 0 0 0 0 0 0 0 0 0 0 0 Izayoba rose extract 0 3 0 0 0 0 0 0 0 0 0 0 0 0 Evening primrose extract 0 0 3 0 0 0 0 3 0 0 3 Meliroth extract 0 0 0 3 0 0 0 0 0 0 0 0 0 Melissa extract 0 0 0 0 3 3 0 0 0 0 3 3 0 0 Lavender extract 0 0 0 0 3 0 0 0 0 0 0 0 Peony extract 0 0 0 0 0 0 0 3 3 0 3 0 0 0 Licorice extract 0 0 0 0 0 0 0 0 0 3 0 3 0 0 POE (20) Sorbetane monolauric acid ester 0.5 「 undefined undefined undefined undefined undefined undefined undefined undefined POE (15) lauryl alcohol ether 0.5 undefined undefined undefined undefined undefined undefined undefined undefined undefined undefined undefined alcohol 8 undefined undefined undefined undefined undefined undefined undefined undefined undefined undefined undefined perfume qs undefined undefined undefined undefined undefined undefined undefined undefined 〃 〃 〃 Preservative 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 〃 ───────────────────── Evaluation ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ △ △
【0014】表2より、ロイヤルゼリーより抽出した天
然エキスと高麗人参から抽出した天然エキスの2者併用
だけでは肌荒れ改善効果がほとんど認められないが、前
記の植物生薬のうち1種又は2種以上配合した系では肌
荒れ改善効果が相乗的に増大することが理解される。From Table 2, it can be seen that the combination of the natural extract extracted from royal jelly and the natural extract extracted from ginseng hardly improves the rough skin, but one or more of the above herbal medicines are used. It is understood that the blended system synergistically increases the rough skin improving effect.
【0015】〔レプリカ法による実使用試験〕健康な女
性パネラーの顔面の皮膚表面形態をシリコーン樹脂によ
るレプリカ法をもちいて肌のレプリカを採り、顕微鏡
(17倍)にて観察した。皮紋の状態及び角層の剥離状
態から、表3に示す基準に基づいて肌荒れを評価し、評
点が1又は2と判断されたパネラーを1群20名とし、
顔面の右半分に表4記載の配合例1又は2のローション
を、左半分に比較例1のローションをそれぞれ1日2回
塗布した。2週間後、再びレプリカを採り、肌の状態を
観察、前記と同様に評価した。[Actual Use Test by Replica Method] The skin surface morphology of the face of a healthy female panelist was taken using a replica method using a silicone resin, and a skin replica was taken and observed under a microscope (17 times). From the state of the skin pattern and the peeling state of the stratum corneum, the skin roughness was evaluated based on the criteria shown in Table 3, and the panelists judged to have a score of 1 or 2 were 20 persons per group,
The lotion of Formulation Example 1 or 2 shown in Table 4 was applied to the right half of the face, and the lotion of Comparative Example 1 was applied to the left half twice a day. Two weeks later, a replica was taken again and the skin condition was observed and evaluated in the same manner as above.
【0016】 (表3) ──────────────────────────────────── 評点 評 点 の 基 準 ──────────────────────────────────── 1 皮溝、皮丘の消失、広範囲の角層のめくれが認められる。 2 皮溝、皮丘が不鮮明、角層のめくれが認められる。 3 皮溝、皮丘は認められるが、平坦。 4 皮溝、皮丘が鮮明。 5 皮溝、皮丘が鮮明で整っている。。 ────────────────────────────────────(Table 3) ──────────────────────────────────── Rating Standards of Rating ─────────────────────────────────── 1 Disappearance of skin crevices, cuticles, and widening of the stratum corneum Is recognized. 2 Unsmooth skin groove and crust, and horny turn of the stratum corneum. 3 There are pits and ridges, but they are flat. 4 Clear skin grooves and ridges. 5 Crusts and ridges are clear and well organized. . ────────────────────────────────────
【0017】角群において、肌荒れ改善効果を次のよう
に判定した。 判定 ○:評点が4又は5と評価されたパネラーの割合が75
%以上 △:評点が4又は5と評価されたパネラーの割合が25
%以上75%未満 ×:評点が4又は5と評価されたパネラーの割合が25
%未満 結果を表4に示す。 (表4) ──────────────────────────────────── 成 分 実施例11 実施例12 比較例3 ──────────────────────────────────── ローヤルゼリーエキス 1.5 1.5 − 高麗人参エキス 1.5 1.5 − イザヨイバラエキス 1.0 1.0 − メリッサエキス 1.0 − − メリロートエキス − 1.0 − グリセリン − − 5.0 ホホバオイル 1.0 1.0 1.0 プロピレングリコール 1.0 1.0 1.0 クエン酸 0.2 0.2 0.2 エタノール 10.0 10.0 10.0 POE(60)硬化ヒマシ油 0.5 0.5 0.5 香料 適量 適量 適量 精製水 残余 残余 残余 ──────────────────────────────────── 評 価 ○ ○ △In the corner group, the rough skin improving effect was determined as follows. Judgment: The proportion of panelists who were evaluated as 4 or 5 was 75.
% Or more △: The proportion of panelists evaluated as 4 or 5 is 25
% Or more and less than 75% x: The proportion of panelists evaluated as 4 or 5 is 25
The results are shown in Table 4. (Table 4) ──────────────────────────────────── Component Example 11 Example 12 Comparative example 3 ──────────────────────────────────── Royal Jelly Extract 1.5 1.5-Ginseng Extract 1 .5 1.5-Iizaibara extract 1.0 1.0-Melissa extract 1.0-Melito extract-1.0-Glycerin-5.0 Jojoba oil 1.0 1.0 1.0 Propylene glycol 1. 0 1.0 1.0 Citric acid 0.2 0.2 0.2 Ethanol 10.0 10.0 10.0 10.0 POE (60) hydrogenated castor oil 0.5 0.5 0.5 Perfume proper amount proper amount purified water Residual Residual Residual ──────────────────────────────────── ○ ○ △
【0018】表4から判るように、本発明にかかる皮膚
外用剤は肌荒れ改善効果に優れた皮膚外用剤である。As can be seen from Table 4, the external preparation for skin according to the present invention is an external preparation for skin excellent in the effect of improving rough skin.
【0019】以下の実施例13〜16の皮膚外用剤を常
法により調整したところ、何も肌荒れ防止、改善効果を
示す優れた皮膚外用剤であった。When the following external preparations for skin of Examples 13 to 16 were prepared by a conventional method, they were excellent external preparations for skin that exhibited rough skin prevention and improvement effects.
【0020】 実施例13 栄養クリーム スクワラン 2.0 セチルイソオクタノエート 5.0 デカメチルシクロペンタシロキサン 15.0 ジメチルポリシロキサン 5.0 有機変性粘土鉱物 2.0 ジグリセロールジオレート 2.0 プロピレングリコール 10.0 ヒアルロン酸ナトリウム 0.1 高麗人参エキス 1.0 ローヤルゼリーエキス 1.0 甘草エキス 0.5 アルブチン 3.0 米胚芽エキス 0.5 防腐剤 適量 香料 適量 エデト酸三ナトリウム 0.05 精製水 残余Example 13 Nutrition cream Squalane 2.0 Cetyl isooctanoate 5.0 Decamethylcyclopentasiloxane 15.0 Dimethylpolysiloxane 5.0 Organically modified clay mineral 2.0 Diglyceroldiolate 2.0 Propylene glycol 10.0 Sodium hyaluronate 0.1 Korean ginseng extract 1.0 Royal jelly extract 1.0 Licorice extract 0.5 Arbutin 3.0 Rice germ extract 0.5 Preservatives proper amount Fragrance proper amount Trisodium edetate 0.05 Purified water Residue
【0021】 実施例14 乳液 スクワラン 5.0 ホホバオイル 2.0 オレイルオレート 3.0 ワセリン 2.0 ステアリン酸 1.0 自己乳化型モノステアリン酸グリセリン 0.8 POE(5)グリセリルモノステアレート 1.2 エタノール 3.0 グリセリン 5.0 ジプロピレングリコール 5.0 カリボキシビニルポリマー 0.2 水酸化カリウム 0.1 グリチルリチン酸塩 0.1 高麗人参エキス 3.0 ローヤルゼリーエキス 5.0 イザヨイバラエキス 0.5 月見草エキス 1.0 香料 適量 防腐剤 適量 精製水 残余Example 14 Emulsion Squalane 5.0 Jojoba oil 2.0 Oleyloylate 3.0 Vaseline 2.0 Stearic acid 1.0 Self-emulsifying glyceryl monostearate 0.8 POE (5) glyceryl monostearate 1. 2 Ethanol 3.0 Glycerin 5.0 Dipropylene glycol 5.0 Carboxy vinyl polymer 0.2 Potassium hydroxide 0.1 Glycyrrhizinate 0.1 Ginseng extract 3.0 Royal jelly extract 5.0 Isaioba rose extract 0.5 Evening primrose extract 1.0 Perfume Suitable amount Preservative Suitable amount Purified water Residual
【0022】 実施例15 乳液 ステアリン酸 0.5 ワセリン 2.0 流動パラフィン 3.0 グリセリン 4.0 1、3−ブチレングリコール 3.0 メトキシケイ皮酸オクチル 0.5 ヘキサメチルジシクロキサン(8cSt) 1.5 ヘキサメチルシクロポリシロキサン(6cSt) 2.0 アルキル変性カルボキビニルポリマー 0.1 カルボキシビニルポリマー 0.2 水酸化カリウム 0.1 多孔質球状シリカ粉末 3.0 α−酢酸トコフェロール 0.05 高麗人参エキス 6.0 ローヤルゼリーエキス 3.0 イザヨイバラエキス 1.0 シャクヤクエキス 1.5 ラベンダーエキス 5.0 香料 適量 防腐剤 適量 精製水 残余Example 15 Emulsion Stearic acid 0.5 Vaseline 2.0 Liquid paraffin 3.0 Glycerin 4.0 1,3-butylene glycol 3.0 Octyl methoxycinnamate 0.5 Hexamethyldicycloxane (8 cSt) 1.5 Hexamethylcyclopolysiloxane (6cSt) 2.0 Alkyl-modified carboxyvinyl polymer 0.1 Carboxyvinyl polymer 0.2 Potassium hydroxide 0.1 Porous spherical silica powder 3.0 α-Tocopherol acetate 0.05 Koryo Ginseng extract 6.0 Royal jelly extract 3.0 Iza yoibara extract 1.0 Peony extract 1.5 Lavender extract 5.0 Perfume proper amount Preservative proper amount Purified water Residual
【0023】 実施例16 化粧水 エタノール 10.0 1,3 ブチレングリコール 6.5 グリセリン 1.0 ホホバオイル 0.5 POE(5)オレイルアルコールエーテル 0.3 POE(20)ソルビタンモノステアリン酸エステル 1.5 dl−α−トコフェロール2−L−アスコルビン酸 リン酸ジエステルカリウム塩 0.1 高麗人参エキス 10.0 ローヤルゼリーエキス 3.0 ヒアルロン酸ナトリウム 0.5 シャクヤクエキス 1.5 香料 適量 防腐剤 適量 精製水 残余Example 16 Lotion lotion Ethanol 10.0 1,3 Butylene glycol 6.5 Glycerin 1.0 Jojoba oil 0.5 POE (5) oleyl alcohol ether 0.3 POE (20) sorbitan monostearate 1. 5 dl-α-tocopherol 2-L-ascorbic acid phosphoric acid diester potassium salt 0.1 ginseng extract 10.0 royal jelly extract 3.0 sodium hyaluronate 0.5 peony extract 1.5 fragrance proper amount preservative proper amount purified water residual
【0024】[0024]
【発明の効果】本発明の皮膚外用剤は、ローヤルゼリー
より抽出される抽出物と、高麗人参より抽出される抽出
物と、植物生薬とを配合することにより肌荒れ防止、肌
荒れ改善効果の高い皮膚外用剤提供するものである。EFFECT OF THE INVENTION The external preparation for skin of the present invention is a combination of an extract extracted from royal jelly, an extract extracted from ginseng, and a botanical herb for preventing rough skin and for improving the rough skin. The agent is provided.
Claims (2)
x Ginseng)抽出物と、植物生薬とを配合することを特徴
とする皮膚外用剤。1. A royal jelly extract and ginseng (Pana)
x Ginseng) extract, and a botanical herbal medicine are blended, and a skin external preparation.
生薬が米胚芽(Oryza sativa Linne) 、イザヨイバラ
(Rosa roxburghii)、月見草(Evenig primrose)、メリ
ロート(Melilotus Officinals) 、メリッサ(Melissa o
fficinalis L.)、ラベンダー(Lavandaula officinali
s)、シャクヤク(Paeonia lactiflora pallas) 、甘草(G
lycyrrhiza glabra linne)から抽出された天然エキスの
1種又は2種以上であることを特徴とする皮膚外用剤。2. The external preparation for skin according to claim 1, wherein the botanical herb is rice germ (Oryza sativa Linne), Rosa roxburghii, Evening primrose, Melililotus Officinals, Melissa o.
fficinalis L.), lavender (Lavandaula officinali
s), peony (Paeonia lactiflora pallas), licorice (G
An external preparation for skin, which is one or more natural extracts extracted from lycyrrhiza glabra linne).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8121027A JPH09286709A (en) | 1996-04-18 | 1996-04-18 | Preparation for external use for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8121027A JPH09286709A (en) | 1996-04-18 | 1996-04-18 | Preparation for external use for skin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09286709A true JPH09286709A (en) | 1997-11-04 |
Family
ID=14801009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8121027A Pending JPH09286709A (en) | 1996-04-18 | 1996-04-18 | Preparation for external use for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH09286709A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240549A (en) * | 2000-03-01 | 2001-09-04 | Pola Chem Ind Inc | Immunopotentiator and composition containing the same |
JP2002193731A (en) * | 2000-12-27 | 2002-07-10 | Kanebo Ltd | Cosmetic |
JP2002308752A (en) * | 2001-04-06 | 2002-10-23 | Nikko Chemical Co Ltd | Skin care preparation |
WO2003015724A1 (en) * | 2001-08-21 | 2003-02-27 | Shiseido Company, Ltd. | Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof |
JP2007320970A (en) * | 2007-09-10 | 2007-12-13 | Naris Cosmetics Co Ltd | Cosmetic |
KR20170136956A (en) * | 2016-06-02 | 2017-12-12 | 주식회사 엘지생활건강 | Composition for skin improvement comprising multiple extract |
CN114028441A (en) * | 2021-12-07 | 2022-02-11 | 海南回元堂药业有限公司 | Shenhuang ointment and preparation method and application thereof |
-
1996
- 1996-04-18 JP JP8121027A patent/JPH09286709A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240549A (en) * | 2000-03-01 | 2001-09-04 | Pola Chem Ind Inc | Immunopotentiator and composition containing the same |
JP2002193731A (en) * | 2000-12-27 | 2002-07-10 | Kanebo Ltd | Cosmetic |
JP2002308752A (en) * | 2001-04-06 | 2002-10-23 | Nikko Chemical Co Ltd | Skin care preparation |
WO2003015724A1 (en) * | 2001-08-21 | 2003-02-27 | Shiseido Company, Ltd. | Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof |
JP2007320970A (en) * | 2007-09-10 | 2007-12-13 | Naris Cosmetics Co Ltd | Cosmetic |
KR20170136956A (en) * | 2016-06-02 | 2017-12-12 | 주식회사 엘지생활건강 | Composition for skin improvement comprising multiple extract |
CN114028441A (en) * | 2021-12-07 | 2022-02-11 | 海南回元堂药业有限公司 | Shenhuang ointment and preparation method and application thereof |
CN114028441B (en) * | 2021-12-07 | 2022-11-29 | 海南回元堂药业有限公司 | Shenhuang ointment and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3483988B2 (en) | Skin preparation | |
JPH08119825A (en) | Hydroxytyrosol, application for skin external medicine or bathing agent | |
JP3053368B2 (en) | Cosmetic and method for producing the same | |
KR100892888B1 (en) | Substances capable of enhancing laminin 5 production in epidermal cells and their use | |
JP2002080338A (en) | Antiaging skin care preparation | |
US6214352B1 (en) | Tyrosinase inhibiting agent | |
JPH07277939A (en) | Skin external preparation | |
JP4070065B2 (en) | Skin preparation for preventing and improving skin roughness | |
JP2002003358A (en) | Skin care preparation | |
JPH04305512A (en) | External preparation for skin | |
JPS63166815A (en) | Skin external preparation | |
US5518722A (en) | Skin regenerating cosmetic composition | |
JPH09286709A (en) | Preparation for external use for skin | |
JP3172753B2 (en) | Biological hyaluronic acid synthesis promoter | |
JP3667291B2 (en) | Topical skin preparation | |
JP3432175B2 (en) | Cell growth promotion cosmetics | |
JPH07215838A (en) | Skin external agent | |
JP2000159653A (en) | Preparation for external use for skin | |
JP2003238429A (en) | Fibroblast cell-activating agent and skin external agent containing the same | |
JP3792745B2 (en) | Tyrosinase inhibitor | |
JPH10194946A (en) | Wrinkle improving agent and skin lotion | |
JP5057638B2 (en) | Topical skin preparation | |
JP2002068956A (en) | Skin cosmetics | |
JP6823938B2 (en) | Topical skin agent | |
JP2000063226A (en) | Skin preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20030924 |